{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:06:41Z","timestamp":1786738001603,"version":"build-2736575974"},"reference-count":57,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2011,9,9]],"date-time":"2011-09-09T00:00:00Z","timestamp":1315526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vet Comparative Oncology"],"published-print":{"date-parts":[[2012,6]]},"abstract":"<jats:p>The purpose of this study was to assess the toxicoses and antitumor activity of metronomic chlorambucil at a dosage of 4 mg m<jats:sup>\u22122<\/jats:sup>daily in dogs with naturally occurring cancer. Thirty\u2010six dogs were enrolled in the study. The protocol was well tolerated with no grade 3 or 4 toxicoses noted. Complete remission was achieved, and lasted over 35 weeks in three dogs (mast cell tumour, soft tissue sarcoma and thyroid carcinoma). Partial remission was noted in 1 dog with histiocytic sarcoma (39 weeks duration) for an overall remission rate of 11% (4 of 36). Stable disease was noted in 17 dogs (47%) with various other cancers. The median progression\u2010free interval was 61 days, and the median survival time was 153 days. Chlorambucil given in a metronomic protocol showed antitumor activity in dogs with a variety of naturally occurring cancers.<\/jats:p>","DOI":"10.1111\/j.1476-5829.2011.00280.x","type":"journal-article","created":{"date-parts":[[2011,9,9]],"date-time":"2011-09-09T17:17:19Z","timestamp":1315588639000},"page":"102-112","source":"Crossref","is-referenced-by-count":59,"title":["Prospective trial of metronomic chlorambucil chemotherapy in dogs with naturally occurring cancer"],"prefix":"10.1111","volume":"10","author":[{"given":"T. N.","family":"Leach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. O.","family":"Childress","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. N.","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. S.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. E.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. R.","family":"Schrempp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. R.","family":"Lahrman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. W.","family":"Knapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,9,9]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1006\/jtbi.2003.3162"},{"key":"e_1_2_6_3_2","first-page":"1878","article-title":"Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug\u2010resistant cancer.","volume":"60","author":"Browder T","year":"2000","journal-title":"Cancer Research"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI35180"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4741.2009.00783.x"},{"key":"e_1_2_6_6_2","first-page":"65.","article-title":"Cyclophosphamide \u201cmetronomic\u201d chemotherapy for palliative treatment of a young patient with advanced epithelial ovarian cancer.","volume":"7","author":"Samaritani R","year":"2007","journal-title":"Biomed Central Cancer"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2004.08.006"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11713"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-006-0347-x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604311"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-199810000-00018"},{"key":"e_1_2_6_12_2","first-page":"133","article-title":"Novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high\u2010risk non\u2010small cell lung cancer patients.","volume":"16","author":"Correale P","year":"2006","journal-title":"Oncology Reports"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-199706000-00022"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601259"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22382"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1215\/15228517-2007-006"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21381"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1080\/07357900600705599"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-072160558-6.50026-5"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-072160558-6.50003-4"},{"key":"e_1_2_6_21_2","first-page":"171","volume-title":"Textbook of Bladder Cancer","author":"Knapp DW.","year":"2006"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-10-0049"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2008.0179.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2007.tb03019.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2460\/javma.1986.189.02.214","article-title":"Chronic lymphocytic leukemia in the dog: 22 cases (1974\u20131984).","volume":"189","author":"Leifer CE.","year":"1986","journal-title":"Journal of the Veterinary Medical Association"},{"key":"e_1_2_6_26_2","first-page":"119","article-title":"Diagnosis and management of monoclonal gammopathies.","volume":"7","author":"MacKewan EG","year":"1977","journal-title":"Veterinary Clinics of North America Small Animal Practice"},{"key":"e_1_2_6_27_2","first-page":"769","volume-title":"Withrow & MacEwen's Small Animal Clinical Oncology","author":"Vail DM.","year":"2007"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0773.2000.pto870506.x"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1983.tb01494.x"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0305-7372(79)80005-5"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0305-7372(79)80008-0"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00578555"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(76)90019-8"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2008.09.015"},{"key":"e_1_2_6_35_2","first-page":"4342","article-title":"Maximum tolerable dose and low\u2010dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells.","volume":"63","author":"Bertolini F","year":"2003","journal-title":"Cancer Research"},{"key":"e_1_2_6_36_2","first-page":"194","article-title":"Veterinary co\u2010operative oncology group\u2010common terminology criteria for adverse events (VCOG\u2010CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats version 1.0.","volume":"2","author":"Veterinary Co\u2010Operative Oncology Group.","year":"2004","journal-title":"Veterinary and Comparative Oncology"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.3.205"},{"key":"e_1_2_6_38_2","first-page":"473","volume-title":"Cancer: Principles & Practice of Oncology","author":"Simon RM.","year":"2005"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600610"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/798467"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-065X.2001.1820102.x"},{"key":"e_1_2_6_42_2","first-page":"291","volume-title":"Withrow & MacEwen's Small Animal Clinical Oncology","author":"Duncan B","year":"2007"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002800000147"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1369"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/scientificamerican0708-64sp"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.9.1051"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mvr.2007.05.003"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcibr0902054"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2346"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdj066"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1080\/07357900600705599"},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1159\/000118626"},{"key":"e_1_2_6_53_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-5827.2009.00732.x"},{"key":"e_1_2_6_54_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0109"},{"key":"e_1_2_6_55_2","first-page":"785","volume-title":"Withrow & MacEwen's Small Animal Clinical Oncology","author":"Thamm DH.","year":"2007"},{"key":"e_1_2_6_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2004.01.008"},{"key":"e_1_2_6_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0945-053X(03)00005-2"},{"key":"e_1_2_6_58_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2135406100"}],"container-title":["Veterinary and Comparative Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5829.2011.00280.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5829.2011.00280.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T08:39:29Z","timestamp":1741595969000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5829.2011.00280.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,9]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["10.1111\/j.1476-5829.2011.00280.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5829.2011.00280.x","archive":["Portico"],"relation":{},"ISSN":["1476-5810","1476-5829"],"issn-type":[{"value":"1476-5810","type":"print"},{"value":"1476-5829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,9]]}}}